Insulin glargine, recombinant Subcutaneous and Ranitidine Suspension
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Ranitidine Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: ranitidine
Brand name: Zantac
Synonyms: Ranitidine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Ranitidine Syrup
- Insulin glargine, recombinant Subcutaneous-Ranitidine Tablets
- Insulin glargine, recombinant Subcutaneous-Ranitidine Tablets and Capsules
- Insulin glargine, recombinant Subcutaneous-Ranolazine
- Insulin glargine, recombinant Subcutaneous-Ranolazine ER Tablets
- Insulin glargine, recombinant Subcutaneous-Rapaflo
- Ranitidine Suspension-Insulin glulisine
- Ranitidine Suspension-Insulin Glulisine (Cartridges and Pens)
- Ranitidine Suspension-Insulin Glulisine (Vials)
- Ranitidine Suspension-Insulin glulisine Subcutaneous
- Ranitidine Suspension-Insulin human inhaled Inhalation
- Ranitidine Suspension-Insulin human regular Injection